2013
DOI: 10.32607/20758251-2013-5-4-118-122
|View full text |Cite
|
Sign up to set email alerts
|

Intensity of Free Radical Processes in Rat Liver under Type 2 Diabetes and Introduction of Epifamin

Abstract: The effect of epifamin on free radical processes, the activity of caspase-1 and -3, aconitate hydratase and citrate content in rat’s liver at experimentally induced type 2 diabetes mellitus (T2DM) was studied. The action of epifamin at T2DM leads to a decrease in biochemiluminescence parameters, characterizing the intensity of free radical processes, and changes in aconitase activity and citrate level towards the control. Activities of caspase-1 and caspase-3 in the tissue decreased by a factor of 2.4 and 1.6 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 10 publications
0
3
0
Order By: Relevance
“…The oxidative modification of proteins valuation method is based on the interaction between oxidized amino acid residues and 2.4-dinitrophenylhydrazine (2.4-DNPH) that forms 2.4-DNPHs[10]. Protein load was identified by the biuret test.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The oxidative modification of proteins valuation method is based on the interaction between oxidized amino acid residues and 2.4-dinitrophenylhydrazine (2.4-DNPH) that forms 2.4-DNPHs[10]. Protein load was identified by the biuret test.…”
Section: Methodsmentioning
confidence: 99%
“…Aconitate hydratase (AH) activity was estimated using the Hitachi U-1900 spectrophotometer supplied with software at 233 nm in the medium that contained 0.05 mmol/L of Tris-HC1-buffer (pH 7.8) and 4 mmol/L of sodium citrate (PanReac, Barcelona, Spain)[10].…”
Section: Methodsmentioning
confidence: 99%
“…According to forecasts experts of the International Diabetes Federation, the number of patients with type 2 diabetes by 2025 year will reach about 380 million people [8]. The main cause of mortality with type 2 diabetes there are macro-and microvascular complications, which are believed to be the cause hyperglycemia, which is the same factor risk of developing atherosclerosis and the heart vascular mortality, as well as the level of total and arterial cholesterol pressure [9].…”
mentioning
confidence: 99%